Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KBSA301 in severe S. aureus pneumonia
NCT01589185Phase 2Completed
- Sponsor
- Aridis Pharmaceuticals, Inc.
- Start
- May 2012
- Primary completion
- May 2016
- Modality
- Monoclonal Antibodies
- Countries
- 4
01
Overview
A Phase 2 trial of tosatoxumab in Staphylococcus aureus pneumonia, sponsored by Aridis Pharmaceuticals, Inc.. Started May 2012; status: completed.
02
Drugs
tosatoxumab
03
Conditions
Staphylococcus aureus pneumonia
Beyond the preview
Go deeper on NCT01589185.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01589185.